Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adicet Bio
Adicet Bio
(ACET)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dactolisib
neoplasms
,
multiple hamartoma syndrome
,
leukemia
,
myeloid leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
breast neoplasms
,
neoplasm metastasis
,
neuroendocrine tumors
,
islet cell adenoma
,
renal cell carcinoma
,
carcinoma
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
covid-19
,
infections
,
communicable diseases
,
kidney neoplasms
,
transitional cell carcinoma
,
perivascular epithelioid cell neoplasms
,
endometrial neoplasms
,
glioblastoma
,
gliosarcoma
,
respiratory tract infections
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use